Israel Englander’s Organon & Co OGN Stock Holding History

Israel Englander’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-300,000	Closed	-$1.8M	–	6254
2026 Q1	$1.8M	Buy	+300,000	New	+$2.26M	﹤0.01%	3974
2025 Q4	–	Sell	-64,900	Closed	-$693K	–	6323
2025 Q3	$693K	Sell	64,900 -197,900	-75%	-$1.94M	﹤0.01%	4877
2025 Q2	$2.54M	Buy	262,800 +162,800	+163%	+$1.68M	﹤0.01%	3665
2025 Q1	$1.49M	Sell	100,000 -350,000	-78%	-$5.38M	﹤0.01%	4055
2024 Q4	$6.71M	Buy	+450,000	New	+$7.33M	﹤0.01%	2550
2024 Q3	–	Sell	-302,800	Closed	-$6.27M	–	6366
2024 Q2	$6.27M	Buy	302,800 +248,500	+458%	+$4.94M	﹤0.01%	2506
2024 Q1	$1.02M	Sell	54,300 -45,700	-46%	-$784K	﹤0.01%	4274
2023 Q4	$1.44M	Buy	100,000 +50,000	+100%	+$680K	﹤0.01%	3862
2023 Q3	$868K	Sell	50,000 -100,500	-67%	-$2.1M	﹤0.01%	4284
2023 Q2	$3.13M	Buy	+150,500	New	+$3.27M	﹤0.01%	3100
2022 Q3	–	Sell	-25,000	Closed	-$844K	–	7373
2022 Q2	$844K	Buy	+25,000	New	+$876K	﹤0.01%	4533

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Israel Englander's OGN Position: Q2 2026 in Review

Israel Englander reduced its Organon & Co (OGN) stake by 49% in Q2 2026, selling an estimated $39.9M and leaving 3,442,430 shares worth $46.6M. The position accounts for 0.02% of the portfolio, ranked #948.

Israel Englander first reported a position in OGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $88M in Q2 2025. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

Israel Englander held 3,442,430 shares of Organon & Co worth $46.6M as of Q2 2026.
Israel Englander sold 3,339,105 Organon & Co shares in Q2 2026, an estimated $39.9M.
Organon & Co made up 0.02% of Israel Englander's portfolio in Q2 2026, its #948 holding.
Israel Englander first reported a position in Organon & Co in Q2 2021 and has held it in 20 quarters since.
Israel Englander's Organon & Co position peaked at $88M in Q2 2025.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.